Omnia M. Khamis

Omnia M. Khamis

Auto-generated profile, based on publicly available information

Omnia M. Khamis

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAbed Alrahman Chouaib
Abed Alrahman Chouaib
HCHsin-Fang Chang
Hsin-Fang Chang
OKOmnia M. Khamis
Omnia M. Khamis
NANadia Alawar
Nadia Alawar
SESantiago Echeverry
Santiago Echeverry
UBUte Becherer
Ute Becherer
Activity recognition in live-cell imaging is labor-intensive and requires significant human effort. Existing automated analysis tools are largely limited in versatility. We present the Intelligent Vesicle Exocytosis Analysis (IVEA) platform, an ImageJ plugin for automated, reliable analysis of fluorescence-labeled vesicle fusion events and other burst-like activity. IVEA includes three specialized modules for detecting: (1) synaptic transmission in neurons, (2) single-vesicle exocytosis in any cell type, and (3) nano-sensor-detected exocytosis. Each module uses distinct techniques, including deep learning, allowing the detection of rare events often missed by humans at a speed estimated to be approximately 60 times faster than manual analysis. IVEA’s versatility can be expanded by refining or training new models via an integrated interface. With its impressive speed and remarkable accuracy, IVEA represents a seminal advancement in exocytosis image analysis and other burst-like fluorescence fluctuations applicable to a wide range of microscope types and fluorescent dyes.

6 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAbed Alrahman Chouaib
Abed Alrahman Chouaib
HCHsin-Fang Chang
Hsin-Fang Chang
OKOmnia M. Khamis
Omnia M. Khamis
SESantiago Echeverry
Santiago Echeverry
LDLucie Demeersseman
Lucie Demeersseman
UBUte Becherer
Ute Becherer
Vesicle exocytosis is a fundamental component of intercellular communication, in all organisms. It has been studied for decades, using various imaging tools. Nevertheless, exocytosis research is still limited by the lack of reliable automated analysis procedures. To address this, we developed the Intelligent Vesicle Exocytosis Analysis Platform (IVEA), a nearly universal solution for analyzing exocytosis acquired with live cell imaging. IVEA is applicable to a wide variety of experimental model systems, microscopes and reporter fluorophores. IVEA combines state-of-the-art deep-learning and computer vision regimes to enable fully automated analysis of large data. IVEA runs as a FIJI plugin and does not require prior training or human intervention. IVEA is 60 times faster than manual analysis and is able to detect rare events often missed by the human eye. Overall, IVEA represents a breakthrough in the analysis of cellular secretory mechanisms and has a transformative potential for the exocytosis imaging field.

12 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
OKOmnia M. Khamis
Omnia M. Khamis
MSMohammad Shkeir
Mohammad Shkeir
CSClaudia Schirra
Claudia Schirra
STSzu-Min Tu
Szu-Min Tu
CCChiara Cassioli
Chiara Cassioli
UBUte Becherer
Ute Becherer
Cytotoxic T lymphocytes (CTLs) eliminate infected and cancerous cells by exocytosing cytotoxic granules, either as single-core granules (SCGs) releasing diffusible Granzyme B and Perforin, or as multi-core granules (MCGs) releasing these effectors as thrombospondin-1/4-encapsulated supramolecular attack particles (SMAPs). How CTLs differentially deploy these granule types remains unclear. We demonstrate that prolonged in vitro expansion and restimulation selectively enhance SMAP release, correlating with increased MCG maturation and thrombospondin-4 expression. Using high-resolution imaging, we identify fusion-competent MCG intermediates lacking SMAPs but releasing granzyme B diffusively. Mechanistically, interferon-γ upregulates thrombospondin-4, driving MCG maturation and SMAP biogenesis, enhancing late-phase CTL killing efficiency against resistant targets. Consistent with this, THBS1 and THBS4 transcript levels appear elevated in melanoma-infiltrating CTLs compared with those during acute adenovirus infection. These findings define a stimulus-dependent, interferon-γ–driven pathway tailoring CTL responses to chronic pathology and highlight opportunities for SMAP-targeted immunotherapies.